In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amersham Life Science Ltd.

Division of General Electric Co.

Latest From Amersham Life Science Ltd.

Singapore’s MerLion Completes Phase III Finafloxacin Studies For Outer Ear Infection, Looks Ahead To Other Indications

Singapore-based MerLIon Pharmaceuticals has reached another milestone with its finafloxacin antibiotic with the topic form for outer ear infection successfully passing Phase III trials in North America. But the firm is still looking for help taking another indication into Phase III.

BioPharmaceutical Singapore

Sweden’s Reference Pricing Proposal: A Five-Year Doomsday Clock For Innovation?

Sweden may link its existing value-based pricing system with international reference pricing to cut drug expenditure, a move the pharmaceuticals industry says would devastate domestic R&D there.

BioPharmaceutical Europe
See All

Company Information